Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Emerging Role of Micrornas As Liquid Biopsy Biomarkers in Lung Cancer: A Review Publisher



Bahadori M1 ; Dabiri S2 ; Azizi MH3 ; Bahadori N1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pathology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Pathology, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
  3. 3. Academy of Medical Sciences, Tehran, Iran

Source: Acta Medica Iranica Published:2021


Abstract

The emergence of patient-tailored medicine has changed all measurable disease outcomes. Among human diseases, cancers appear to be the most dangerous. Furthermore, lung cancers rank the first among human cancers in both morbidity and mortality. When lung cancer is clinically diagnosed, it is often too late for therapy. The absence of accurate and specific tools for early detection results in a poor prognosis for lung cancer. The discovery of microRNAs and their function in lung cancer offers a new mechanism for the detection of lung cancer cells. These molecules, derived from cancerous cells, circulate in the patient's blood. Recently, a revolutionary technique, i.e., liquid biopsy has shown promise in discovering these circulating microRNAs molecules in body fluids, namely peripheral blood. A liquid biopsy allows the detection and isolation of circulating tumor cells, circulating nucleotides, and cellular exosome as a source of genomic and proteomic information in cancerous patients, especially in the early stages of cancer cell development. In this review, by searching various databases, including PubMed, Google Scholar, and Scopus, we explore liquid biopsy as a novel tool and the application of miRNAs in lung cancer detection in diagnostic pathology. © 2021 Tehran University of Medical Sciences. All rights reserved.
Related Docs
View other Related Docs
1. Microfluidics for Detection of Exosomes and Micrornas in Cancer: State of the Art, Molecular Therapy Nucleic Acids (2022)
2. Overview of Liquid Biopsy, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
3. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)
4. Prostate Cancer and Noncoding Rnas: A Focus on Mirnas, Lncrnas, and Circrnas, Prostate Cancer: Molecular Events and Therapeutic Modalities (2024)
5. Potential Theranostics of Circulating Tumor Cells and Tumor-Derived Exosomes Application in Colorectal Cancer, Cancer Cell International (2020)
6. Liquid Biopsy in Thyroid Cancer: New Insight, International Journal of Hematology-Oncology and Stem Cell Research (2018)
7. Microrna-155 and Its Exosomal Form: Small Pieces in the Gastrointestinal Cancers Puzzle, Cell Biology and Toxicology (2024)
8. Tumor-Educated Platelets, Clinica Chimica Acta (2024)
Experts (# of related papers)
View all Related Experts
Hamid Reza Mirzaei (7)
Seyed Mohammad Kazem Aghamir Mohammad Ali (4)
Other Related Docs
9. Micrornas in Cancer, Synthesis Lectures on Biomedical Engineering (2022)
10. Exosomal Micrornas in Regulation of Tumor Cells Resistance to Apoptosis, Biochemistry and Biophysics Reports (2024)
11. Low Expression of Talin1 Is Associated With Advanced Pathological Features in Colorectal Cancer Patients, Scientific Reports (2020)
12. Exosomes and Lung Cancer: Roles in Pathophysiology, Diagnosis and Therapeutic Applications, Current Medicinal Chemistry (2021)
13. Evaluation of Mir-122 Level in the Plasma of Chronically Hcv Infected Patients, Molecular Biology (2016)
14. Effect of Il-27 on Activity of Bone Marrow Nk Cells of Patient With B-Chronic Lymphocytic Leukemia in Vitro, Koomesh (2021)
15. Liquid Biopsy As a Minimally Invasive Source of Thyroid Cancer Genetic and Epigenetic Alterations, International Journal of Molecular and Cellular Medicine (2019)
16. Immunogenic Cell Death (Icd)-Inducers in Non-Small-Cell Lung Carcinoma (Nsclc): Current Knowledge and Future Perspective, Clinical and Translational Oncology (2023)
17. Anti-Cd20 Antibody Treatment for B-Cell Malignancies, Resistance to Anti-CD20 Antibodies and approaches for their Reversal: Volume 2 (2023)
18. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study, JAMA Oncology (2019)
19. Recent Advances in Immune Checkpoint Therapy in Non-Small Cell Lung Cancer and Opportunities for Nanoparticle-Based Therapy, European Journal of Pharmacology (2021)
20. Evaluation of Circulating Serum 3 Types of Microrna As Biomarkers of Oral Squamous Cell Carcinoma; a Pilot Study, Journal of Oral Pathology and Medicine (2020)
21. Critical Considerations for Investigating Micrornas During Tumorigenesis: A Case Study in Conceptual and Contextual Nuances of Mir-211-5P in Melanoma, Epigenomes (2023)
22. Tio2 Nanoparticles Enhance the Chemotherapeutic Effects of 5-Fluorouracil in Human Ags Gastric Cancer Cells Via Autophagy Blockade, Life Sciences (2020)
23. Circulating Micrornas in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers, Current Pharmaceutical Design (2016)
24. The Role of Cxc Chemokines and Receptors in Breast Cancer, Clinical and Experimental Medicine (2025)
25. Effects of Micro Rnas and Their Targets in Periodontal Diseases, Infectious Disorders - Drug Targets (2018)
26. Glioma and Exosome, Letters in Applied NanoBioScience (2022)
27. Role of Resveratrol in Modulating Micrornas in Human Diseases: From Cancer to Inflammatory Disorder, Current Medicinal Chemistry (2021)
28. Microrna a New Gate in Cancer and Human Disease: A Review, Journal of Biological Sciences (2017)
29. Recent Advances on High-Efficiency of Micrornas in Different Types of Lung Cancer: A Comprehensive Review, Cancer Cell International (2023)
30. Communication Between Stromal and Hematopoietic Stem Cell by Exosomes in Normal and Malignant Bone Marrow Niche, Biomedicine and Pharmacotherapy (2020)
31. Paper-Based Biosensors As Point-Of-Care Diagnostic Devices for the Detection of Cancers: A Review of Innovative Techniques and Clinical Applications, Frontiers in Oncology (2023)
32. Liquid Biopsy in Female Genital Tract (Ovarian Cancer, Endometrial Tumor, and Cervical Tumor), Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
33. Diagnostic and Therapeutic Potential of Exosomes in Cancer: The Beginning of a New Tale?, Journal of Cellular Physiology (2017)
34. Micrornas As Biomarkers for Early Diagnosis, Targeting and Prognosis of Prostate Cancer, Pathology Research and Practice (2023)
35. Immunotherapy of Gastric and Esophageal Cancers, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
36. Changes and Challenges in Sexual Life Experienced by the Husbands of Women With Breast Cancer: A Qualitative Study, BMC Women's Health (2022)
37. Investigating Socioeconomic Inequality in the Incidence of Breast Cancer in Iran: Interprovincial Analysis and Comparison, Scientific Journal of Kurdistan University of Medical Sciences (2025)
38. Role of Non-Coding Rnas As New Therapeutic Targets in Regulating the Emt and Apoptosis in Metastatic Gastric and Colorectal Cancers, Cell Cycle (2023)
39. The Therapeutic Potential of Mesenchymal Stem Cell–Derived Exosomes in Treatment of Neurodegenerative Diseases, Molecular Neurobiology (2019)
40. Tumor Immunology, Clinical Immunology (2022)
41. Liquid Biopsy in Kidney Tumor, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
42. Tumor-Derived Urinary Exosomal Long Non-Coding Rnas As Diagnostic Biomarkers for Bladder Cancer, EXCLI Journal (2020)
43. Downregulation of Plasma Mir-142-3P and Mir-26A-5P in Patients With Colorectal Carcinoma, International Journal of Cancer Management (2015)
44. Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid Tumors, Epigenetics Insights (2020)
45. A Global, Regional, and National Survey on Burden and Quality of Care Index (Qci) of Hematologic Malignancies; Global Burden of Disease Systematic Analysis 1990–2017, Experimental Hematology and Oncology (2021)
46. Tumor Acidic Environment Directs Nanoparticle Impacts on Cancer Cells, Journal of Colloid and Interface Science (2023)
47. Plasma Mir-183-5P in Colorectal Cancer Patients As Potential Predictive Lymph Node Metastasis Marker, Journal of Cancer Research and Therapeutics (2022)
48. Exosomal Long Non-Coding Rnas: Novel Molecules in Gastrointestinal Cancers’ Progression and Diagnosis, Frontiers in Oncology (2022)
49. Reproducible and Reliable Real-Time Pcr Assay to Measure Mature Form of Mir-141, Applied Immunohistochemistry and Molecular Morphology (2016)
50. Non-Coding Rnas in Leukemia Drug Resistance: New Perspectives on Molecular Mechanisms and Signaling Pathways, Annals of Hematology (2024)